CoChat

Selective 5‐hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?

MAXTON, D. G., MORRIS, J., WHORWELL, P. J. · 1996 · Alimentary Pharmacology & Therapeutics
Cited by 96

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background: Abnormalities of gut motility and visceral pain perception are both thought to be involved in the pathogenesis of irritable bowel syndrome and may be susceptible to modulation by drugs affecting the various 5‐HT receptor subtypes. The aim of this study was to investigate the therapeutic potential of a 5‐HT 3 antagonist in irritable bowel syndrome. Methods: Fifty patients with irritable bowel syndrome were treated with ondansetron, a highly selective 5‐HT 3 antagonist, in a double‐blind, placebo‐controlled cross‐over study. In addition to assessing its effect on the classical symptoms of irritable bowel syndrome (abdominal pain, distension and disordered bowel habit) its effect on symptoms often seen in irritable bowel syndrome, but more commonly associated with functional dyspepsia, was also examined. Results: Ondansetron reduced bowel frequency (P=0.035) and improved stool consistency (P=0.002) in diarrhoea predominant irritable bowel syndrome and did not cause a deterioration of bowel habit in constipation predominant subjects. No statistically significant improvement was seen for abdominal pain or distension, although those patients who did respond were approximately twice as likely to be taking ondansetron than placebo. It was also found that ondansetron significantly improved the upper gastrointestinal symptoms of post‐prandial epigastric discomfort (P=0.008), flatulence (P=0.022) and heartburn (P=0.003). Conclusion: The results of this study justify evaluation of the therapeutic potential of selective 5‐HT antagonists in both functional dyspepsia and irritable bowel syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.1996.30172000.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 96

Metadata

Authors
MAXTON, D. G., MORRIS, J., & WHORWELL, P. J.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
1996-08
Volume
10
Issue
4
Pages
595-599
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2011663436
Cited by
96
References
1
FWCI
5.24
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective 5‐hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia? https://app.cochat.ai/papers/10.1046/j.1365-2036.1996.30172000.x
The paper
MAXTON, D. G., MORRIS, J., & WHORWELL, P. J. (1996). Selective 5‐hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia? Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1996.30172000.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.